Absci Corp. (ABSI)
8.45
+0.20
(+2.42%)
USD |
NASDAQ |
Oct 19, 14:47
Absci Cash from Operations (Annual) : -92.92M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -92.92M |
| December 31, 2024 | -72.40M |
| December 31, 2023 | -64.64M |
| December 31, 2022 | -81.34M |
| Date | Value |
|---|---|
| December 31, 2021 | -60.60M |
| December 31, 2020 | -10.97M |
| December 31, 2019 | -6.032M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Twist Bioscience Corp. | -47.63M |
| Prime Medicine, Inc. | -162.56M |
| Beam Therapeutics, Inc. | -345.10M |
| Moderna, Inc. | -1.873B |
| Tenax Therapeutics, Inc. | -35.80M |